Could a simple protein help kids fight COVID-19?
NCT ID NCT05855330
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether giving arginine (a natural protein) by IV can improve how cells produce energy in children hospitalized with COVID-19. About 21 kids aged 3 to 21 will receive one of three doses three times a day for up to five days. Researchers will measure changes in mitochondrial function and amino acid levels to see if arginine helps recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- arginine (a protein given by IV infusion)
- What this could lead to
- If it works, this could point toward a simple, safe treatment to help children recover faster from COVID-19 by boosting energy in their cells.
- What could go wrong
- This is a very small early-phase pilot study with only 21 children, so results may not be conclusive. Arginine can cause side effects like flushing, nausea, or headache.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Healthcare of Atlanta (CHOA), Arthur M. Blank
RECRUITINGAtlanta, Georgia, 30322, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?